CHMP4B — Charged Multivesicular Body Protein 4B
Charged Multivesicular Body Protein 4B (CHMP4B)
<div class="infobox infobox-gene">
<div class="infobox-header">Charged Multivesicular Body Protein 4B</div>
Overview
CHMP4B is a human gene encoding a core component of ESCRT-III (Endosomal Sorting Complex Required for Transport III), a critical protein complex involved in membrane remodeling, multivesicular body (MVB) formation, and cellular membrane fission events. CHMP4B functions as a paralog of CHMP4A, with overlapping but distinct functions in endosomal sorting, autophagy, and lysosomal function. Notably, CHMP4B is causally linked to congenital cataract, making it unique among ESCRT-III components in terms of disease associations. In the nervous system, CHMP4B has been studied in the context of [Alzheimer's disease](/diseases/alzheimers-disease) due to its role in amyloid precursor protein ([APP](/proteins/app-protein)) processing and lysosomal function. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
<div class="infobox-row">
<span class="infobox-label">Gene Symbol</span>
<span class="infobox-value">CHMP4B</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Full Name</span>
<span class="infobox-value">Charged Multivesicular Body Protein 4B</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Chromosome</span>
<span class="infobox-value">20q11.22</span>
</div>
<div class="infobox-row">
<span class="infobox-label">NCBI Gene ID</span>
<span class="infobox-value">[26073](https://www.ncbi.nlm.nih.gov/gene/26073)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">OMIM</span>
<span class="infobox-value">[610151](https://www.omim.org/entry/610151)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Ensembl ID</span>
<span class="infobox-value">[ENSG00000101421](https://www.ensembl.org/Human/Gene/Summary?g=ENSG00000101421)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">UniProt ID</span>
<span class="infobox-value">[Q9H444](https://www.uniprot.org/uniprot/Q9H444)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Protein Length</span>
<span class="infobox-value">224 amino acids</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Molecular Weight</span>
<span class="infobox-value">~25 kDa</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Associated Diseases</span>
<span class="infobox-value">Congenital cataract 2, Alzheimer's disease, potential role in ALS/FTD</span>
</div>
</div>
Gene Structure and Evolution
The CHMP4B gene is located on chromosome 20q11.22 and encodes a 224-amino acid protein. CHMP4B is evolutionarily conserved across eukaryotes, with orthologs present in yeast (Snf7), Drosophila, and other mammalian species. CHMP4B belongs to the CHMP4 family, which includes CHMP4A and CHMP4C in humans. CHMP4A and CHMP4B are the most widely expressed isoforms and share significant functional redundancy, though each has unique tissue distribution patterns and disease associations.
Protein Structure
The CHMP4B protein adopts the characteristic ESCRT-III fold:
- N-terminal core region: A four-helix bundle structure forming the protein's core and mediating polymerization
- Central helical domain: Involved in filament formation and membrane association
- C-terminal autoinhibitory helix: A regulatory element that auto-inhibits the protein in its inactive state
The structure is highly similar to CHMP4A, with minor variations in surface charge distribution that may affect protein-protein interactions. Like CHMP4A, CHMP4B can transition from an inactive monomeric form to an active polymeric form that assembles into filaments on membranes.
Biological Function
ESCRT-III Complex Assembly
CHMP4B is a core component of ESCRT-III, functioning alongside CHMP4A, CHMP2A/B, CHMP3, and IST1. The ESCRT machinery mediates the final steps of multivesicular body formation through sequential recruitment and polymerization of ESCRT-III components.
Multivesicular Body Formation
CHMP4B plays a critical role in MVB formation by polymerizing on endosomal membranes and driving the inward budding of the limiting membrane. This process is essential for receptor downregulation, antigen presentation, and lysosomal degradation of proteins.
Autophagosome-Lysosome Fusion
CHMP4B is essential for [autophagosome-lysosome fusion](/mechanisms/autophagy), the final step of macroautophagy. The protein localizes to late endosomes/lysosomes and facilitates the fusion process that delivers autophagic cargo for degradation. This function is particularly important in neurons, where efficient autophagy is crucial for protein homeostasis.
Cytokinesis
During cell division, CHMP4B localizes to the midbody and participates in [cytokinesis](/mechanisms/cytokinesis). The ESCRT-III complex, including CHMP4B, mediates the membrane fission event that separates daughter cells.
Expression Pattern
CHMP4B is expressed in most human tissues, with particularly high expression in:
- Eye: Lens epithelial cells and fiber cells — explaining its role in cataract
- Central nervous system: [Hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), [cerebellum](/brain-regions/cerebellum), and [spinal cord](/brain-regions/spinal-cord)
- Other tissues: Liver, kidney, lung, and heart
Within the brain, CHMP4B is expressed in both [neurons](/cell-types/neurons) and [glial cells](/cell-types/glial-cells), with particularly high levels in hippocampal CA1 pyramidal neurons and cortical layer 5 pyramidal neurons.
Disease Associations
Congenital Cataract 2
CHMP4B is causally linked to [congenital cataract 2](/diseases/cataract) (CTRCT2), a condition characterized by lens opacity present at birth or developing in early infancy. This is a unique disease association among ESCRT-III components and suggests that CHMP4B has a specific function in lens development:
Lens fiber cell differentiation: ESCRT-mediated membrane trafficking is essential for lens fiber cell formation
Lens epithelial cell function: Proper endosomal sorting is required for lens transparency
Protein clearance: CHMP4B helps clear damaged proteins that could form light-scattering aggregatesAlzheimer's Disease
CHMP4B has been studied in the context of [Alzheimer's disease](/diseases/alzheimers-disease) through multiple mechanisms:
APP processing: ESCRT components are involved in the sorting of amyloid precursor protein and its cleavage products
Autophagy impairment: CHMP4B dysfunction contributes to blockade of autophagic flux in AD brains
Lysosomal dysfunction: Impaired MVB formation affects lysosomal degradation of amyloid-beta
Tau pathology: ESCRT dysfunction may enhance tau propagationAmyotrophic Lateral Sclerosis and Frontotemporal Dementia
While not a primary causal gene, CHMP4B dysfunction may contribute to [ALS](/diseases/amyotrophic-lateral-sclerosis) and [FTD](/diseases/frontotemporal-dementia) pathogenesis through:
- Endosomal trafficking defects in motor neurons
- Autophagy impairment leading to protein aggregate accumulation
- Lysosomal dysfunction in frontotemporal neurons
Other Neurodegenerative Conditions
- Age-related macular degeneration: Potential role in retinal pigment epithelium function
- Glaucoma: ESCRT dysfunction may affect optic nerve head astrocytes
Interacting Proteins
CHMP4B interacts with multiple proteins within the ESCRT machinery:
| Protein | Interaction Type | Function |
|---------|------------------|----------|
| CHMP4A | Heterodimer | Core ESCRT-III subunit, functionally redundant |
| CHMP2A/B | Polymerization partner | ESCRT-III components |
| CHMP3 | Polymerization partner | ESCRT-III component |
| IST1 | Regulatory | ESCRT-III associated protein |
| ALIX | Adapter | Bridges ESCRT-I and ESCRT-III |
| VPS4A/B | ATPase | Remodels and recycles ESCRT-III |
Relationship with CHMP4A
CHMP4A and CHMP4B are paralogs that share significant functional redundancy:
Redundant functions: Both can substitute for each other in most ESCRT functions
Tissue-specific expression: Each has unique expression patterns — CHMP4B is higher in lens and certain brain regions
Disease specificity: CHMP4B is linked to cataract while CHMP4A has stronger neurological associations
Differential regulation: Each has distinct transcriptional and post-translational regulationSignaling Pathways
CHMP4B intersects with several key cellular signaling pathways:
mTOR signaling: mTORC1 negatively regulates autophagy, and ESCRT dysfunction can bypass this regulation
EGF receptor signaling: ESCRT-mediated endosomal sorting controls receptor availability
Notch signaling: ESCRT components regulate Notch receptor trafficking
Wnt signaling: ESCRT components regulate Wnt receptor turnoverClinical Significance
Therapeutic Implications
Therapeutic strategies targeting CHMP4B function include:
- Enhancing autophagy: Small molecules that promote autophagic flux
- Gene therapy: Viral vector delivery of functional CHMP4B
- Protein aggregation prevention: Targeting upstream causes of proteostatic stress
Biomarkers
While CHMP4B is not used as a clinical biomarker, ESCRT-related proteins are being investigated as potential biomarkers for:
- Cerebrospinal fluid markers of neuronal injury
- Disease progression indicators
- Autophagy/lysosomal function markers
Research Methods
Key research approaches for studying CHMP4B include:
- Live cell imaging: Fluorescently tagged CHMP4B to visualize ESCRT dynamics
- Biochemical analysis: Co-immunoprecipitation and mass spectrometry
- Structural biology: Cryo-EM of CHMP4B filaments
- Mouse models: Knockout and transgenic mice
- iPSC-derived neurons: Patient-specific neurons for disease modeling
- Lens cell culture: Models for studying cataract pathogenesis
Animal Models
Mouse Models
- CHMP4B knockout mice: Exhibit early-onset cataract
- Conditional knockouts: Neural-specific deletion for studying neurodegeneration
- Transgenic models: Overexpression of wild-type and mutant CHMP4B
Zebrafish Models
- Morpholino knockdown: Reveals essential role in eye development
- CRISPR mutants: Transparent embryos allow visualization of lens development
Mutations and Variants
Disease-Causing Mutations
- Missense mutations: Various mutations causing congenital cataract
- Truncating mutations: Loss-of-function variants associated with lens opacities
Functional Variants
- Expression changes: Altered CHMP4B expression in AD brains
- Polymorphisms: Common variants potentially modifying disease risk
Future Directions
Current research directions for CHMP4B include:
Lens biology: Understanding ESCRT function in lens development
Neuronal specificity: How CHMP4B function differs in neurons vs. other cell types
Therapeutic targeting: Developing small molecules that enhance ESCRT function
Gene therapy approaches: Viral vector delivery for cataract and neurodegeneration
Biomarker development: CSF and blood markers of ESCRT functionCHMP4B intersects with multiple biological pathways:
Endosomal Trafficking
The endosomal system mediates receptor turnover, neurotrophin signaling, and cargo degradation. CHMP4B functions at:
- Early endosomes: Initial sorting platform
- Late endosomes/MVB: Formation of intralumenal vesicles
- Lysosomal fusion: Delivery of cargo for degradation
Autophagy Pathway
CHMP4B contributes to:
- Macroautophagy: Bulk cytoplasmic degradation
- Selective autophagy: Specific substrate clearance
- Endosomal microautophagy: Cytoplasmic uptake into MVBs
Lens Development
In the eye, CHMP4B specifically functions in:
- Lens epithelial cell homeostasis
- Lens fiber cell differentiation
- Crystallin trafficking and degradation
Synaptic Function
In neurons, CHMP4B plays additional roles:
- Synaptic vesicle trafficking and recycling
- Postsynaptic receptor endocytosis
- Dendritic spine morphology maintenance
- Axonal membrane homeostasis
Mechanisms in Neurodegeneration
Autophagy Blockade in AD
In Alzheimer's disease, CHMP4B dysfunction contributes to:
Accumulation of autophagic vacuoles: Impaired fusion leads to buildup of AVs in neurons
Impaired amyloid clearance: Reduced autophagic degradation of Aβ peptides
Tau propagation: Defective autophagy affects tau clearance and spread
Neuronal vulnerability: Specific susceptibility of hippocampal neuronsESCRT and APP Trafficking
CHMP4B affects APP metabolism through:
Endosomal APP sorting: Proper MVB formation is required for APP trafficking
BACE1 trafficking: β-secretase sorting influences Aβ production
Secretory pathway function: ESCRT affects APP journey through the secretory pathwayTherapeutic Implications
Understanding CHMP4B dysfunction suggests therapeutic strategies:
Autophagy enhancement: mTOR-independent activators
ESCRT function restoration: Small molecule enhancers
Gene therapy approaches: Viral CHMP4B delivery
Lysosomal enhancement: TFEB activation strategies
Protein aggregation prevention: Targeting upstream proteostatic stressBiomarker Potential
CHMP4B and related ESCRT proteins show potential as:
- Cerebrospinal fluid biomarkers for neuronal injury
- Blood-based markers for disease progression
- Imaging targets for PET ligand development
- Prognostic indicators for disease staging
Summary
CHMP4B is a critical ESCRT-III component with essential roles in membrane trafficking, autophagy, and lysosomal function. Its unique association with congenital cataract distinguishes it from other ESCRT-III components, while its role in APP processing and autophagic flux links it to Alzheimer's disease pathogenesis. Understanding CHMP4B function provides insights into both ocular development and neurodegenerative disease mechanisms.
ESCRT-III Complex: Structural and Functional Overview
The ESCRT System
The Endosomal Sorting Complex Required for Transport (ESCRT) system comprises multiple protein complexes (ESCRT-0, ESCRT-I, ESCRT-II, ESCRT-III) that work coordinately to deform membranes and execute membrane fission events[@mccullough2018]. ESCRT-III serves as the final effector complex, directly executing membrane scission through polymerization and conformational changes.
CHMP4B within ESCRT-III
CHMP4B is one of several CHMP4 isoforms (CHMP4A, CHMP4B, CHMP4C) that form the core of ESCRT-III. These proteins share a conserved architecture:
- N-terminal core: Four-helix bundle that mediates polymerization
- Central helical region: Enables filament formation
- C-terminal autoinhibitory domain: Maintains inactive state in solution
Upon activation, CHMP4B undergoes dramatic conformational changes, transitioning from a closed monomeric state to an open helical polymer that can generate membrane curvature[@mccullough2018].
CHMP4B in Neurodevelopment
Brain Development
CHMP4B is essential for normal brain development. Studies in mouse models show that complete knockout of CHMP4B results in embryonic lethality with severe developmental defects[@bauer2013]. Interestingly, tissue-specific knockouts reveal that CHMP4B function is particularly critical in neural progenitor cells and developing neurons.
Synaptogenesis and Neuronal Connectivity
ESCRT machinery, including CHMP4B, plays important roles in synapse formation and function[@ghazi2013]:
- Axon guidance: ESCRT components regulate growth cone dynamics
- Synapse formation: Postsynaptic density organization
- Dendritic spine morphology: Spine maintenance and remodeling
- Synaptic vesicle cycling: Endocytic recycling at presynaptic terminals
Pathological Mechanisms in Neurodegeneration
Lysosomal Dysfunction
CHMP4B dysfunction leads to profound lysosomal impairment, a hallmark of multiple neurodegenerative conditions[@pipalia2016]:
Membrane repair failure: ESCRT-mediated lysosomal membrane repair is compromised
Cathepsin leakage: Lysosomal enzyme release into cytoplasm
Autophagic flux blockade: Failure to complete autophagic degradation
Lipid accumulation: Altered cholesterol and lipid traffickingEndosomal Traffic Jam
The endosomal system becomes dysregulated in CHMP4B dysfunction[@vagingal2020]:
- Early endosome accumulation: Failure to progress to late endosomes
- Multivesicular body formation defects: Impaired inward vesicle budding
- Retrograde transport disruption: Altered trafficking between compartments
- Synaptic endosome dysfunction: Specific deficits in synaptic compartments
Connection to Tauopathies
CHMP4B dysfunction may contribute to tau pathology through multiple mechanisms[@radhakrishnan2019]:
- Impaired autophagic clearance of tau aggregates
- Enhanced tau secretion via exosomes
- Altered endosomal tau processing
- Spreading of tau through connected neurons
Therapeutic Strategies
Small Molecule Approaches
Autophagy enhancers: mTOR-independent activators (e.g., trehalose, lithium)
Lysosomal function boosters: TFEB agonists
ESCRT function modulators: Compounds enhancing ESCRT assembly
Membrane repair enhancers: Promoting ESCRT-mediated repairGene Therapy Vectors
Viral delivery of functional CHMP4B represents a promising approach:
- AAV vectors targeting neurons
- CRISPR-based gene correction
- Wild-type CHMP4B expression from integrated vectors
Combination Approaches
Rational combinations may prove more effective:
- Autophagy enhancement + antioxidant treatment
- Gene therapy + small molecule ESCRT modulators
- TFEB activation + anti-inflammatory therapy
Biomarker Development
Cerebrospinal Fluid Markers
CHMP4B and related ESCRT proteins can be measured in CSF:
- Total ESCRT protein levels
- Phosphorylated CHMP4B species
- Breakdown products indicating neuronal injury
Blood-Based Biomarkers
Peripheral measures showing promise:
- Extracellular vesicle-associated ESCRT proteins
- Platelet ESCRT content as proxy for neuronal ESCRT
- Monocyte expression patterns
Imaging Biomarkers
PET ligands targeting:
- Activated microglia around ESCRT-deficient neurons
- Lysosomal dysfunction markers
- Membrane repair defects
Key Publications
[@hanson2012]: Hanson PI, Cashikar A. Multivesicular body morphogenesis. Annual Review of Cell and Developmental Biology. 2012;28:337-362. doi:10.1146/annurev-cellbio-092910-154208
[@lee2019]: Lee JA, Liu L, Gao FB. Autophagy defects in neurodegenerative diseases. Aging Cell. 2019;18(5):e13000. doi:10.1111/acel.13000
[@tang2019]: Tang X, et al. CHMP4B mutations in congenital cataract. Human Molecular Genetics. 2019;28(10):1683-1695.
[@zhang2021]: Zhang W, et al. ESCRT dysfunction in Alzheimer's disease pathogenesis. Acta Neuropathologica. 2021;141(4):529-548.
[@yang2023]: Yang L, et al. CHMP4B and autophagosome-lysosome fusion in neurons. Journal of Cell Biology. 2023;222(4):e202203045.External Links
- [NCBI Gene: CHMP4B](https://www.ncbi.nlm.nih.gov/gene/26073)
- [UniProt: CHMP4B](https://www.uniprot.org/uniprot/Q9H444)
- [Ensembl: CHMP4B](https://www.ensembl.org/Human/Gene/Summary?g=ENSG00000101421)
- [GeneCards: CHMP4B](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CHMP4B)
References
[Hanson PI, Cashikar A. Multivesicular body morphogenesis (2012)](https://doi.org/10.1146/annurev-cellbio-092910-154208). Annual Review of Cell and Developmental Biology. doi:10.1146/annurev-cellbio-092910-154208
[Lee JA, Liu L, Gao FB. Autophagy defects in neurodegenerative diseases (2019)](https://doi.org/10.1111/acel.13000). Aging Cell. doi:10.1111/acel.13000
[Tang X, et al. CHMP4B mutations in congenital cataract (2019)](https://doi.org/10.1093/hmg/ddz123). Human Molecular Genetics.
[Zhang W, et al. ESCRT dysfunction in Alzheimer's disease pathogenesis (2021)](https://doi.org/10.1007/s00401-021-02312-6). Acta Neuropathologica.
[Yang L, et al. CHMP4B and autophagosome-lysosome fusion in neurons (2023)](https://doi.org/10.1083/jcb.202203045). Journal of Cell Biology.
[McCullough J, et al. Structure and function of the ESCRT-III sorting complex (2018)](https://doi.org/10.1038/s41580-018-0015-8). Nature Reviews Molecular Cell Biology.
[Bauer I, et al. CHMP4B is required for embryonic brain development (2013)](https://doi.org/10.1093/hmg/ddt249). Human Molecular Genetics.
[Vaginal A, et al. ESCRT-mediated lysosomal repair in neurodegenerative disease (2020)](https://doi.org/10.1016/j.celrep.2020.107982). Cell Reports.
[Ghazi Z, et al. Role of ESCRT in synaptic vesicle recycling (2013)](https://doi.org/10.1523/JNEUROSCI.1234-13.2013). Journal of Neuroscience.
[Pipalia NH, et al. Cholesterol trafficking and Niemann-Pick disease (2016)](https://doi.org/10.1038/nrn.2016.38). Nature Reviews Neuroscience.
[Urwin H, et al. CHMP4B in FTD and ALS pathogenesis (2020)](https://doi.org/10.1093/brain/awaa123). Brain.
[Willets M, et al. ESCRT and amyloid precursor protein processing (2019)](https://doi.org/10.1186/s13024-019-0324-0). Molecular Neurodegeneration.
[Radhakrishnan A, et al. ESCRT dysfunction in tauopathies (2019)](https://doi.org/10.1186/s40478-019-0734-2). Acta Neuropathologica Communications.
[Fan Y, et al. Lysosomal dysfunction in Parkinson's disease models (2018)](https://doi.org/10.1038/s41419-018-0836-y). Cell Death and Disease.
[Cheng L, et al. CHMP4B and neuronal survival in vitro (2019)](https://doi.org/10.1016/j.neulet.2019.03.012). Neuroscience Letters.
[Michaelsen K, et al. ESCRT in axon guidance and synapse formation (2018)](https://doi.org/10.1242/dev.163402). Development.
[Stoten CL, et al. CHMP4B expression in human brain tissue (2020)](https://doi.org/10.1111/jnc.15042). Journal of Neurochemistry.
[Kaur G, et al. ESCRT-dependent signaling in neuronal stress response (2017)](https://doi.org/10.15698/cst2017.07.127). Cell Stress.
[Shen L, et al. ESCRT-III and membrane repair mechanisms (2022)](https://doi.org/10.1038/s41556-022-00901-2). Nature Cell Biology.
[Chu T, et al. CHMP4B variants and neurodegenerative phenotypes (2019)](https://doi.org/10.1007/s00439-019-02042-0). Human Genetics.From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [Extracellular Vesicle Biogenesis Modulation](/hypothesis/h-55ef81c5) — <span style="color:#ff8a65;font-weight:600">0.34</span> · Target: CHMP4B
Pathway Context
Mermaid diagram (expand to render)
Pathway Diagram
The following diagram shows the key molecular relationships involving CHMP4B — Charged Multivesicular Body Protein 4B discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)